SCHEMBL29265059

SCHEMBL29265059

COc1ccc(-c2sc(NC(=O)C(C)C)nc2C)cc1C(=O)NCCCCCCC(=O)NO

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 17/20 0.46
▸ HDAC6 Q9UBN7 15/20 0.46
▸ HDAC2 Q92769 11/20 0.45
▸ HDAC3 O15379 9/20 0.45
▸ HDAC8 Q9BY41 9/20 0.45
▸ HDAC4 P56524 8/20 0.44
▸ HDAC9 Q9UKV0 8/20 0.44
▸ HDAC7 Q8WUI4 7/20 0.44
▸ HDAC10 Q969S8 7/20 0.44
▸ HDAC11 Q96DB2 7/20 0.44
▸ HDAC5 Q9UQL6 7/20 0.44
▸ PIK3CD O00329 2/20 0.43
▸ PIK3CG P48736 1/20 0.43
▸ PI4KB Q9UBF8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29265062 0.89 MAPT (0.52) HDAC1HDAC2PI4KB
SCHEMBL29265051 0.87 MAPT (0.51) HDAC1HDAC2PI4KB
SCHEMBL29265058 0.80 PIK3CD (0.64) PIK3CDPIK3CGPI4KB
SCHEMBL29265077 0.80 MAPT (0.51) PI4KB
SCHEMBL29265053 0.75 PI4KB (0.62) PIK3CDPIK3CGPI4KB
SCHEMBL29265068 0.75 MEN1 (0.52) HDAC1HDAC6HDAC2HDAC3HDAC8
SCHEMBL29265060 0.71 PIK3CD (0.63) PIK3CDPIK3CGPI4KB
SCHEMBL30792284 0.71 PIK3CD (0.58) PIK3CDPIK3CGPI4KB
SCHEMBL29265072 0.69 MAPT (0.53) PI4KB
Butyric Acid SCHEMBL29265074 0.69 MAPT (0.53) PI4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118221610-A Phenylthiazole amine PI4KIII beta/HDAC double-target inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-06-21 — — CN claimed
CN-118221610-A Phenylthiazole amine PI4KIII beta/HDAC double-target inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-06-21 — — CN disclosed
Send feedback